Responsibility towards patients and users
Biotest works in a highly regulated environment in which drug safety and tolerability are of the highest importance. Quality is therefore a primary focus in all phases of research, development and manufacturing of our products, as well as in obtaining the marketing authorisation and sourcing of raw material. Our high safety standards, which exceeds legal regulations, ensure that we meet our own high requirements for quality. Biotest thus applies the strict safety standards of the Plasma Protein Therapeutics Association (PPTA) for obtaining and processing blood plasma.